Stratos Wealth Partners LTD. lifted its holdings in shares of Steris PLC (NYSE:STE) by 19.6% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 9,612 shares of the medical equipment provider’s stock after purchasing an additional 1,573 shares during the quarter. Stratos Wealth Partners LTD.’s holdings in Steris were worth $1,475,000 as of its most recent SEC filing.
Several other hedge funds have also bought and sold shares of the company. CIBC Asset Management Inc boosted its holdings in shares of Steris by 2.6% during the second quarter. CIBC Asset Management Inc now owns 4,295 shares of the medical equipment provider’s stock worth $659,000 after purchasing an additional 108 shares during the last quarter. Raymond James & Associates boosted its holdings in shares of Steris by 1.3% during the second quarter. Raymond James & Associates now owns 308,593 shares of the medical equipment provider’s stock worth $47,351,000 after purchasing an additional 3,901 shares during the last quarter. Cambridge Investment Research Advisors Inc. boosted its holdings in shares of Steris by 17.3% during the second quarter. Cambridge Investment Research Advisors Inc. now owns 5,029 shares of the medical equipment provider’s stock worth $772,000 after purchasing an additional 741 shares during the last quarter. Nisa Investment Advisors LLC boosted its holdings in shares of Steris by 15.4% during the second quarter. Nisa Investment Advisors LLC now owns 22,580 shares of the medical equipment provider’s stock worth $3,465,000 after purchasing an additional 3,012 shares during the last quarter. Finally, Krueger & Catalano Capital Partners LLC boosted its holdings in shares of Steris by 13.1% during the second quarter. Krueger & Catalano Capital Partners LLC now owns 8,814 shares of the medical equipment provider’s stock worth $1,352,000 after purchasing an additional 1,024 shares during the last quarter. Institutional investors and hedge funds own 87.85% of the company’s stock.
Several equities research analysts have recently issued reports on the company. Stephens raised their price objective on Steris from $145.00 to $170.00 and gave the stock an “overweight” rating in a report on Friday, May 15th. Needham & Company LLC assumed coverage on Steris in a report on Tuesday, June 9th. They issued a “hold” rating on the stock. Finally, Zacks Investment Research cut Steris from a “hold” rating to a “sell” rating and set a $158.00 target price on the stock. in a report on Tuesday, July 14th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $164.00.
In other Steris news, Director Mohsen Sohi sold 3,218 shares of the business’s stock in a transaction dated Friday, May 29th. The stock was sold at an average price of $164.12, for a total transaction of $528,138.16. Following the transaction, the director now owns 25,579 shares in the company, valued at $4,198,025.48. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 1.20% of the company’s stock.
Shares of Steris stock opened at $159.63 on Friday. Steris PLC has a twelve month low of $105.69 and a twelve month high of $168.98. The stock has a market capitalization of $13.56 billion, a P/E ratio of 33.47 and a beta of 0.78. The company has a current ratio of 2.40, a quick ratio of 1.91 and a debt-to-equity ratio of 0.37. The business’s fifty day moving average price is $154.02 and its 200 day moving average price is $151.87.
Steris (NYSE:STE) last issued its earnings results on Wednesday, May 13th. The medical equipment provider reported $1.64 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.57 by $0.07. The firm had revenue of $822.99 million for the quarter, compared to analysts’ expectations of $788.37 million. Steris had a return on equity of 16.34% and a net margin of 13.45%. During the same quarter last year, the firm earned $1.53 earnings per share. As a group, sell-side analysts predict that Steris PLC will post 5.23 EPS for the current year.
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Featured Article: How is net asset value different from market price?
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.